MondegarAI
Athos Capital Ltd

Q2 2025 · 13F-HR

Athos Capital Ltdholdings as filed

Filed 2025-08-14 · accession 0001681662-25-000004

$66,860
Reported value
37
Positions
2025-06-30
Period end
View analyzed profile →PRO

The Brief · Athos Capital Ltd · Q2 2025

AI · grounded in 13F

Athos Capital Ltd established a new position in SKAA with an investment of $11,521. The fund also added new holdings in K for $7,197 and CHA for $4,251. Other new entries include GLOBAL BLUE GROUP HOLDING AG at $3,735 and AKX at $3,688.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
830566105SKAASKECHERS U S A INC$11,52117.2%182,588CommonSOLE
487836108KKELLANOVA$7,19710.8%90,500CommonSOLE
15743P104CHACHAGEE HLDGS LTD$4,2516.36%162,800CommonSOLE
H33700107GLOBAL BLUE GROUP HOLDING AG$3,7355.59%500,000CommonSOLE
03662Q105AKXANSYS INC$3,6885.52%10,500CommonSOLE
87652V109TASKTASKUS INC$3,3525.01%200,000CommonSOLE
48203R104JNPJUNIPER NETWORKS INC$3,2344.84%80,999CommonSOLE
344849104WOOFOOT LOCKER INC$3,1854.76%130,000CommonSOLE
62945V109NVEEUSDNV5 GLOBAL INC$3,0024.49%130,000CommonSOLE
46591M109JOYYJOYY INC$2,7954.18%54,900CommonSOLE
92556H2060VVBPARAMOUNT GLOBAL$2,5803.86%200,000CommonSOLE
G2949D120DYNCUDYNAMIX CORP$2,5783.86%250,000CommonSOLE
G32901111FACTUFACT II ACQUISITION CORP$2,5753.85%250,000CommonSOLE
98923K103ZKNZEEKR INTELLIGENT TECHNOLOGY$2,5663.84%100,638CommonSOLE
09627Y1092655787DBLUEPRINT MEDICINES CORP$2,5643.83%20,000CommonSOLE
85205L107SWTXUSDSPRINGWORKS THERAPEUTICS INC$2,3503.51%50,000CommonSOLE
G2003N113BEAGUBOLD EAGLE ACQUISITION CORP$1,0661.59%100,000CommonSOLE
G38268119TGEGENERATION ESSENTIALS GROUP$6590.99%83,331CommonSOLE
460690100IPGINTERPUBLIC GROUP COS INC$6120.92%25,000CommonSOLE
G6717R120OACCUOAKTREE ACQUISITION CORP III$5310.79%50,000CommonSOLE
44852D108HUYAHUYA INC$4480.67%127,346CommonSOLE
G63369113MRNOWMURANO GLOBAL INVTS PLC$4180.63%42,840CommonSOLE
G5380J118LANV/WSLANVIN GROUP HOLDINGS LIMITE$3450.52%157,703CommonSOLE
G20873116CHEB/WSCHENGHE ACQUISITION II CO$3370.50%37,499CommonSOLE
G21301125CCIXUCHURCHILL CAPITAL CORP IX$2690.40%25,000CommonSOLE
G5451A129LEGT/ULEGATO MERGER CORP III$2650.40%25,000CommonSOLE
G29201111ECXWWECARX HOLDINGS INC$1890.28%92,368CommonSOLE
G9845F117LSBWFLAKESHORE BIOPHARMA CO LTD$1320.20%128,981CommonSOLE
25985W204DOYUDOUYU INTL HLDGS LTD$1290.19%19,925CommonSOLE
96812F110BAERWBRIDGER AEROSPACE GRP HLDGS$1270.19%66,062CommonSOLE
20460L112SPWRWCOMPLETE SOLARIA INC$520.08%28,420CommonSOLE
29415V117COCHWENVOY MEDICAL INC$410.06%28,588CommonSOLE
G18932114CPTWFCAPTIVISION INC$370.06%32,075CommonSOLE
M2573A197ZOOZWZOOZ PWR LTD$170.03%17,135CommonSOLE
738920115ASBPWASPIRE BIOPHARMA HLDGS INC$60.01%21,383CommonSOLE
744413113PIIIWP3 HEALTH PARTNERS INC$50.01%37,052CommonSOLE
854936119SDSTWSTARDUST PWR INC$20.00%11,378CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.